<DOC>
	<DOCNO>NCT02520089</DOCNO>
	<brief_summary>Patients humeral shaft pseudoarthrosis go treated standard protocol lock compression plate bone autograft , group patient treat platelet rich plasma . Posteriorly patient evaluate radiographically functional scale period one year .</brief_summary>
	<brief_title>Humeral Shaft Pseudoarthrosis Treated With Bone Autograft Versus Platelet Rich Plasma</brief_title>
	<detailed_description>Pseudarthrosis condition characterize absence union 3-4 month start fracture . It usually symptoms manifested pain loss function affect extremity . In addition radiographic data lack consolidation fracture . The surgical indication patient pseudoarthrosis data presence pain mobility fracture take account time evolution . The humeral shaft fracture represent 3 % general fracture , appear around 66,000 case per year United States . The conservative treatment brace use since 1970 's . Mostly humeral shaft fracture manage option . Contraindications fracture bilateral polytraumatized patient ability roam . Surgical treatment seek provide stable fixation provide early mobilization . The union fracture occurs period range 12 24 week . The use Locking Compression Plate must least six cortical fixation fragment actually recommend , besides necessary applies also bone autograft promote ossification osteogenic , osteoinductive , osteoconductive property , radiographic union nineteen week . The platelet-rich plasma ( PRP ) obtain sample autologous blood , process growth factor stimulate angiogenesis cell proliferation . It use since 1990 treat jaw fracture bone autograft tendon injury rotator cuff good evolution . It bone consolidation 8 24 week . Preparation platelet-rich plasma A 40-ml volume whole blood take basilic antecubital vein upper limb sterile tube vacuum seal 3.8 % sodium citrate anticoagulant . The sample transport Tissue Engineering Laboratory Bone Tissue Bank centrifuge 10 minute 1800 rpm separate cellular part correspond erythrocyte leukocyte . The upper plasma layer remove tube ( take care remove buffy coat ) collect 50-ml sterile conical polypropylene tube second centrifugation step 12 min 3400 rpm . The plasma supernatant , platelet poor plasma , remove , leave volume 3 ml platelet resuspend . The 3 ml PRP obtain transfer sterile glass tube vacuum seal without anticoagulant . An aliquot final PRP send laboratory quantify number platelet . Manipulation sample perform sterile environment within class II biosafety cabinet . Prior administration PRP patient , activation platelet induce add 0.45 ml 10 % calcium gluconate invert sample several time ensure homogeneous mixture . Then , activate PRP aspirate 5-ml syringe application patient use technique describe asepsis application 2 ml lidocaine application site . The patient must sign format inform consent authorization surgery use platelet-rich plasma . After sign informed consent , divide patient two randomized group make comparative longitudinal study . A control group patient receive treatment surgery basis open reduction lock compression plate autologous bone iliac crest . The experimental group patient receive above-mentioned treatment application plasma rich platelet level fracture focus . After surgery patient assess outpatient 10 day evaluation , pendulum exercise first radiographic evaluation . The patient attend consultation continue post-surgical evolution . During follow-up visit , radiographic extent bony callus assess via anteroposterior lateral radiograph arm follow grade 0 , identifiable bony callus ; grade 1 , primary bony callus formation little new periosteal bone ; grade 2 , new periosteal bone formation two side humerus , ; grade 3 , new periosteal bone formation three four side humerus . The follow-up one year . Sample size calculation Using formula test hypothesis two mean difference , value zα 1.96 significance level 95 two tail , value zβ 0.84 output 80 , sample obtain 7 participant per group , whereas average 19 week group control standard deviation 3 hop reduce 4 week start consolidation application PRP .</detailed_description>
	<mesh_term>Pseudarthrosis</mesh_term>
	<criteria>evolution 3 month initial orthopedic management without mental illness osteoporosis contralateral ipsilateral fracture previous fracture place least 3 month hematologic problem liver disease cardiac , renal lung disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>platelet-rich plasma</keyword>
	<keyword>bone grafting</keyword>
	<keyword>pseudoarthrosis</keyword>
</DOC>